Genome-Edited Coincidence and PMP22-HiBiT Fusion Reporter Cell Lines Enable an Artifact-Suppressive Quantitative High-Throughput Screening Strategy for PMP22 Gene-Dosage Disorder Drug Discovery.
ACS Pharmacol Transl Sci
; 4(4): 1422-1436, 2021 Aug 13.
Article
in En
| MEDLINE
| ID: mdl-34423274
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Screening_studies
Language:
En
Journal:
ACS Pharmacol Transl Sci
Year:
2021
Document type:
Article
Affiliation country:
United States
Country of publication:
United States